Evidence map›Paper›PMID 12800944›Full record

ArticleEuropean journal of epidemiology2003

Genotype-phenotype analysis for the polymorphic CA repeat in the insulin-like growth factor-I (IGF-I) gene.

I Kato, J Eastham, B Li, M Smith, H Yu

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of epidemiology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

I KatoKarmanos Cancer Institute/Department of Pathology Wayne State University, Detroit, Michigan 48201, USA. katoi@karmanos.org
J Eastham
B Li
M Smith
H Yu

Funding

ESTROGEN AND INSULIN LIKE GROWTH FACTORS IN BREAST CANCER03CA083050 · NCI · YALE UNIVERSITY · PI YU, HERBERT · 1999 to 2000
$81k
IRON, FOLATE AND FEMALE COLORECTAL CANCER--COHORT STUDYR01CA069201 · NCI · WAYNE STATE UNIVERSITY · PI KATO, IKUKO · 1996 to 1999
–
NCI NIH HHS CA 69201NCI NIH HHS CA 80704NCI NIH HHS CA 83050
6 · The paper itself

Abstract

Polymorphic microsatellite dinucleotide (cytosine-adenine, CA) repeats of the insulin-like growth factor-I (IGF-I) gene may have implications in the development of certain types of cancer and osteoporosis. We studied correlations between IGF-I genotypes determined by direct sequencing and plasma IGF-I levels among 113 healthy individuals (60 men and 53 women), who were originally enrolled as controls for hospital-based case-control studies of breast and prostate cancer. On the contrary to an earlier observation, there were no differences in plasma IGF-I levels between those with and without the allele of 19 repeats. With adjustment for other confounders, there were no trends in plasma IGF-I levels with increasing or decreasing the number of CA repeats among all study subjects combined, all Whites or all Blacks, suggesting no overall functional significance of this polymorphism. Opposite trends observed in gender and racial subgroups, i.e., an inverse association between plasma IGF-I levels and the CA repeat length in white women and a positive association in black men, are likely to be chance findings.

Indexed as

Dinucleotide RepeatsInsulin-Like Growth Factor IAllelesGenotypeHumansPhenotypePolymorphism, GeneticInsulin-Like Growth Factor I

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.